Trials / Completed
CompletedNCT01304303
Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase I study of SPARC1023 alone and in combination with carboplatin
Detailed description
Pharmacokinetic profile and dose escalation study of SPARC1023 when administered as 30-min infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPARC1023 I | IV administration |
| DRUG | SPARC1023 II | IV administration |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2011-02-25
- Last updated
- 2019-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01304303. Inclusion in this directory is not an endorsement.